跳至主要内容
临床试验/NCT05093062
NCT05093062已完成不适用

Efficacy Observation on Tian Jiu Therapy for Asthma

The University of Hong Kong0 个研究点目标入组 136 人开始时间: 2015年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
136
主要终点
The change in the frequency of asthma attack

研究概览

简要总结

Objectives:

To further evaluate the immediate, long-term and cumulative effects of Tian Jiu Therapy on asthma.

Hypothesis to be tested:

The efficacy of Tian Jiu Therapy on asthma is also long-term and will be accumulated.

Design and Subjects:

Recruiting 167 asthma participants who received Tian Jiu Therapy under the primary study of HKCTR-1128. All subjects should be above age 13 and receive the same Tian Jiu Therapy, 3 times per year from 2013 to 2015. A one-year follow-up after the last Tian Jiu treatment will be conducted.

Study instruments:

Modern USB PC-based Spirometer and Fingertip Pulse Oximeter.

Interventions:

Plastering some stimulating Chinese herbal cubes on certain acupoints in the three hottest days of each year, for three consecutive years.

Main outcome measures:

Pulmonary Function Test, Blood Oxygen Test, Quality of Life and Standardized Questionnaire on asthma attack and symptoms will be administered before treatment, after treatment of each year and one-year follow-up after the last treatment.

Data analysis:

All the parameters will be analyzed, the physical improvement (Cured, Remarkably effective, Effective and Ineffective) will be recorded, and the differences in different treatment courses will be investigated and compared with previous data obtained in the primary study of HKCTR-1128 by using standard statistical analysis.

Expected results:

The effect of Tian Jiu Therapy on Asthma is not only immediate but also long-term and will be gradually accumulated.

The Tian Jiu Therapy will acquire better efficacy on asthma if this treatment was conducted more years continuously.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention

入排标准

年龄范围
13 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • History of Asthma
  • Diagnostic Criteria of Asthma according to U.S.DHHS(2007):
  • Episodic symptoms of airflow obstruction
  • Difficulty breathing
  • Chest tightness
  • Cough (worse at night)
  • Symptoms occurring or worsening at night, awakening the patient
  • Symptoms occurring or worsening with exercise, viral infections, changes in weather, strong emotions, or mens; or in the presence of animals, dust mites, mold, smoke, pollen, or chemicals
  • Airflow obstruction at least partially reversible Medically stable and acute medical care does not require. E.g. intensive monitoring, invasive ventilation, haemoid-dialysis, cardiac support.

排除标准

  • Patients currently experiencing Acute asthma attack
  • Infants and child under thirteen years old 3.Pregnant women
  • Patients with
  • Fever and pharyngitis
  • Tuberculosis
  • Severe cardiac and pulmonary diseases
  • Diabetes Mellitus
  • Hypersensitive skin condition
  • Allergy to topical medication
  • Bleeding disorders
  • Severe heart diseases and with pacemaker.

结局指标

主要结局

The change in the frequency of asthma attack

时间窗: baseline, change from baseline at 1-2th week; change from baseline at 12 months after treatment

The change in the frequency of asthma attack

The change in clinic visit

时间窗: baseline, change from baseline at 1-2th week; change from baseline at 12 months after treatment

The change in clinic visit

The change in Quality of life

时间窗: baseline, change from baseline at 1-2th week; change from baseline at 12 months after treatment

The change in Quality of life (SF-36 score)

The change in admission to hospital

时间窗: baseline, change from baseline at 1-2th week; change from baseline at 12 months after treatment

The change in admission to hospital

The change in AE visit

时间窗: baseline, change from baseline at 1-2th week; change from baseline at 12 months after treatment

The change in AE visit

次要结局

  • The change of Pulmonary Function (FEV1/FEC)(baseline, change from baseline at 1-2th week; change from baseline at 12 months after treatment)
  • The change of Pulmonary Function (FEV1)(baseline, change from baseline at 1-2th week; change from baseline at 12 months after treatment)

研究者

申办方类型
Other
责任方
Sponsor

相似试验